Revance Therapeutics
RVNC
#7652
Rank
S$0.48 B
Marketcap
S$4.63
Share price
0.00%
Change (1 day)
-8.29%
Change (1 year)

Revance Therapeutics (RVNC) Fails to deliver data

Key failure to deliver metrics for Revance Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Revance Therapeutics (RVNC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014

Volume in USD (price x number of shares), data since 2014

Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025S$7.42 M7.81%
2024S$6.88 M-84.79%
2023S$45.25 M383.15%
2022S$9.36 M-6.12%
2021S$9.97 M-56.82%
2020S$23.1 M668%
2019S$3 M-97.15%
2018S$0.10 B815.52%
2017S$11.51 M5.25%
2016S$10.93 M-46.65%
2015S$20.5 M-9.25%
2014S$22.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$35.31 MS$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$3.43 MS$74.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
S$1.22 MS$1.25 M๐Ÿ‡บ๐Ÿ‡ธ USA